J Boffa1,2, M Mayan3, S Ndlovu4, D Fisher5,6, S Staples7, R Sauve5,7, T Williamson5. 1. Department of Global Health, Stellenbosch University, Cape Town, South Africa. 2. Research Institute, McGill University Health Centre, McGill University, Montreal, Quebec, Canada. 3. Community University Partnerships, Faculty of Extension, University of Edmonton, Alberta, Canada. 4. Izimbali Zesizwe, Pietermaritzburg, South Africa. 5. Department of Community Health Sciences, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada. 6. Department of Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada. 7. Tuberculosis and HIV Investigative Network (THINK), Durban, South Africa.
Abstract
SETTING: In 2011, the South African government began to offer isoniazid preventive therapy (IPT) through the public health system to presumptively treat latent tuberculous infection (LTBI) among people living with human immunodeficiency virus. OBJECTIVE: To describe IPT perceptions and experiences in three Zulu communities in KwaZulu-Natal Province, South Africa. DESIGN: Using a combination of community-based research and ethnographic methods, we undertook 17 individual and group interviews between October 2014 and May 2015. Interviews transcripts were analysed using qualitative content analysis and validated with grass-roots community advisors. RESULTS: Participants reported multiple ways in which IPT was perceived as dangerous: when costs related to pill collection or consumption were unsustainable, or when daily pill consumption resulted in stigma or was seen to introduce excess dirt or toxins, 'ukungcola', in the body. Theories on dirt are evoked to describe how IPT was perceived as 'matter out of place' when given to people who believed themselves to be healthy, suggesting that under the current TB aetiological model in Zulu culture, 'prevention as tablet' may not fit. CONCLUSION: Implementing IPT without understanding the realities of community stakeholders can unintentionally undermine TB control efforts by worsening the situation for people who already encounter numerous daily problems.
SETTING: In 2011, the South African government began to offer isoniazid preventive therapy (IPT) through the public health system to presumptively treat latent tuberculous infection (LTBI) among people living with human immunodeficiency virus. OBJECTIVE: To describe IPT perceptions and experiences in three Zulu communities in KwaZulu-Natal Province, South Africa. DESIGN: Using a combination of community-based research and ethnographic methods, we undertook 17 individual and group interviews between October 2014 and May 2015. Interviews transcripts were analysed using qualitative content analysis and validated with grass-roots community advisors. RESULTS: Participants reported multiple ways in which IPT was perceived as dangerous: when costs related to pill collection or consumption were unsustainable, or when daily pill consumption resulted in stigma or was seen to introduce excess dirt or toxins, 'ukungcola', in the body. Theories on dirt are evoked to describe how IPT was perceived as 'matter out of place' when given to people who believed themselves to be healthy, suggesting that under the current TB aetiological model in Zulu culture, 'prevention as tablet' may not fit. CONCLUSION: Implementing IPT without understanding the realities of community stakeholders can unintentionally undermine TB control efforts by worsening the situation for people who already encounter numerous daily problems.
Entities:
Keywords:
IPT; South Africa; community-based research; ethnography; tuberculosis
Authors: Martin Gulliford; Jose Figueroa-Munoz; Myfanwy Morgan; David Hughes; Barry Gibson; Roger Beech; Meryl Hudson Journal: J Health Serv Res Policy Date: 2002-07
Authors: Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young Journal: Nat Rev Microbiol Date: 2009-10-26 Impact factor: 60.633
Authors: Dillon T Wademan; Graeme Hoddinott; Susan E Purchase; James A Seddon; Anneke C Hesseling; Anthony J Garcia-Prats; Ria Reis; Lindsey J Reynolds Journal: PLoS One Date: 2022-07-14 Impact factor: 3.752